MEDIPURE PHARMACEUTICALS WELCOMES NEUROLOGY EXPERT DR. GERALD ZAMPONI TO COMPANY'S SCIENTIFIC ADVISORY BOARD
Vancouver, BC - November 28, 2017 - Medipure Pharmaceuticals, a biopharmaceutical incubator committed to discovering and developing proprietary cannabinoid-derived prescription medications, is pleased to announce the addition of Dr. Gerald Zamponi to the company’s Scientific Advisory Board.